U.S. Food and Drug Administration Approves Gilenya to Treat Relapsing Multiple Sclerosis (MS) in Pediatric Patients
Published on
CHOP co-principal investigator heralds first-ever FDA approval of an MS drug for kids as a major step forward.
Published on
CHOP co-principal investigator heralds first-ever FDA approval of an MS drug for kids as a major step forward.
Published on
6ABC interviews a CHOP patient family and neurologist Sarah Hopkins, MD, about acute flaccid myelitis, a condition causing sudden paralysis in some kids.
Published on
The Division of Neurology at CHOP is focused on finding the causes of multiple sclerosis and using the latest diagnosis and treatment technologies to provide the best care possible for patients with MS and their families.
Published on
The 2016 Philadelphia Auto Show’s Black Tie Tailgate broke records, with more than 4,800 people helping to raise over $550,000 for the Division of Neurology.
Published on
CHOP patient Allison Reed, who is treated for pediatric multiple sclerosis, is featured on 6ABC along with Chief of Neurology, Dr. Brenda Banwell.
Published on
A CHOP genome researcher was a co-author of the largest-ever genetic analysis of the chronic neurological disease multiple sclerosis (MS).
Published on
Brenda Banwell, MD, joins The Children's Hospital of Philadelphia as chief of the Division of Neurology. Dr. Banwell is an active researcher with interest in multiple sclerosis and other acquired demyelineating diseases.
Published on
The Center for Applied Genomics at The Children's Hospital of Philadelphia contributed important pediatric data to the largest-ever genetic study of multiple sclerosis (MS), published in the journal Nature.